Effect of Increased Copayments on Pharmacy Use in the Department of Veterans Affairs

OBJECTIVES: In February 2002, the Department of Veterans Affairs (VA) raised medication copayments from $2 to $7 per 30-day supply of medication for certain veteran groups. We examined the impact of the copayment increase on medication acquisition from VA. METHODS: This was a retrospective cohort study using data from national VA databases from February 2001 through February 2003. We took a random sample of over 5% of male VA users in 2001. Of 149,107 veterans sampled, 19,504 (13%) had copayments for no drugs, 101,410 (68%) had copayments for some drugs, and 28,193 (19%) had copayments for all drugs. We used multivariable count models to examine changes in the number of 30-day medication supplies after the increase. RESULTS: After the copayment increase, veterans subject to copayments for all drugs received 8% fewer 30-day supplies of medication annually relative to veterans with no copayments (P < 0.001). The effect of the copayment increased as the number of different medications veterans received increased. Among veterans subject to copayments for all drugs, acquisition of lower-cost drugs fell by 36%, higher-cost medications fell by 6%, over-the-counter medications fell by 40%, and prescription-only medications fell by 4% relative to veterans with no drug copayments. CONCLUSIONS: The number of medications veterans obtained from VA decreased after the copayment increase. There were relatively larger impacts on veterans with higher medication use and on lower-cost and over-the-counter medications

Copayment · Family medicine · Health care · Medical prescription · Veterans Affairs · Demography · Emergency Medicine · Internal Medicine · Medication Adherence and Compliance · Medicine · Pharmaceutical Economics and Policy · Pharmaceutical Practices and Patient Outcomes · Pharmacology · Pharmacy

• The Effect of Increased Travel Reimbursement Rates on Health Care Utilization in the VA

  Open Access•Richard E Nelson, Bret Hicken et al.•The Journal of Rural Health•2012

  Incluir item

• Quality of Antiepileptic Treatment Among Older Medicare Beneficiaries With Epilepsy

  Maria Pisu, Joshua Richman et al.•Medical Care•2017

  Incluir item

• Likelihood Ratio Tests for Model Selection and Non-Nested Hypotheses

  Quang Vuong, Quang H Vuong•Econometrica•1989

  Incluir item

• Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons

  Robyn Tamblyn•JAMA•2001

  Incluir item

• Are Patients at Veterans Affairs Medical Centers Sicker?

  Zia Agha, Richard P Lofgren et al.•A.M.A. Archives of Internal…•2000

  Incluir item

• The Effect of a Medicaid Drug Copayment Program on the Utilization and Cost of Prescription Services

  Arthur A Nelson, C Eugene Reeder et al.•Medical Care•1984

  Incluir item

• Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization

  Brenda Motheral, Brenda R Motheral et al.•Medical Care•2001

  Incluir item

• The demand for prescription drugs as a function of cost-sharing

  Open Access•Arleen Leibowitz, Willard G Manning et al.•Social Science & Medicine•1985

  Incluir item